When depression continues after medication and therapy, people often blame themselves. The problem may instead be treatment-resistant depression, a term commonly used when symptoms have not improved enough after at least two adequate antidepressant trials. A careful psychiatric review can clarify whether earlier treatments had enough time and dose to work, whether side effects limited them, and whether another condition is affecting recovery.
There is still room to make a better plan. For that reason, the next step is usually a fresh evaluation of the diagnosis, treatment history, physical health, sleep, substance use, daily functioning, and safety. That review may lead to a medication change, structured psychotherapy, a combined approach, or a brain-stimulation treatment such as TMS.
Quick guide
- What treatment-resistant depression means
- Seven signs that deserve a closer review
- What does not automatically mean treatment resistance
- What a psychiatric reassessment should cover
- Treatment options after two antidepressants
- How TMS may fit into the plan
- What to bring to an appointment
- When to seek urgent help
What is treatment-resistant depression?
Treatment-resistant depression is major depressive disorder that has not improved enough after at least two antidepressant treatments given at a suitable dose and duration. The National Institute of Mental Health uses the two-antidepressant definition, while the Agency for Healthcare Research and Quality notes that research definitions still vary.[1][2]
The word “adequate” matters. An antidepressant may need 4 to 8 weeks to show its full effect, according to the National Institute of Mental Health.[1] However, some people stop earlier because of side effects, cost, worsening symptoms, missed doses, or difficulty getting follow-up care. Those experiences are clinically important, but a psychiatrist may classify them differently from a completed medication trial that provided little benefit.
The diagnosis is based on more than the number of prescriptions in a chart. A clinician should review what was taken, the dose, the length of treatment, adherence, side effects, symptom change, and the reason the treatment ended.
7 signs of treatment-resistant depression
These signs do not diagnose the condition by themselves. They are reasons to ask for a detailed psychiatric review.
1. Two antidepressant trials did not bring enough relief
You took two different antidepressants as prescribed for an appropriate length of time, yet major symptoms remained. Improvement may have been absent, modest, or too short-lived to restore daily functioning.
Bring the medication names, highest doses, start and stop dates, and what changed. Pharmacy records can help when depression has made dates hard to remember.
2. Symptoms improved, but daily life is still restricted
For example, a person may report feeling “a little better” while still missing work, withdrawing from family, neglecting meals, or spending much of the day in bed. Clinical response and remission are different outcomes. Response usually means a meaningful reduction in symptoms; remission means symptoms have fallen to a minimal level.
In the first treatment step of the large STAR-D study, about one-third of participants reached remission, while another 10% to 15% responded without reaching remission.[3] The study also found that improvement took time: response occurred at nearly 6 weeks on average and remission at nearly 7 weeks.[3]
3. Depression returns soon after an initial improvement
Even after improvement, some people notice symptoms returning within several weeks or months despite continuing treatment. That pattern deserves a review of the diagnosis, adherence, stressors, sleep, medical health, and the long-term treatment plan.
Record the approximate date improvement began, how long it lasted, and which symptoms came back first. Early changes in sleep, concentration, irritability, or social withdrawal can be easier to identify than a single change in mood.
4. Side effects prevent an adequate medication trial
Nausea, sexual problems, agitation, sleep disruption, emotional blunting, or other side effects can make a medication hard to continue. Tell the clinician what happened and how quickly it began. A medication that could not be tolerated still provides useful information for the next decision.
Never stop an antidepressant suddenly without medical guidance. A prescriber can explain how to reduce or change a medication safely and how to monitor symptoms during the transition.
5. Several symptoms remain even when mood improves
Residual symptoms can include poor sleep, low energy, slow thinking, loss of interest, guilt, appetite changes, or trouble concentrating. In one STAR-D analysis of 943 people who reached remission, more than 90% still reported at least one residual depressive symptom, with a median of 3.[4]
That finding does not mean treatment failed. For that reason, follow-up should include specific symptom tracking instead of relying only on the question, “Do you feel better?”
6. The current diagnosis does not fully explain the pattern
Depression can occur alongside anxiety, trauma-related conditions, substance use, chronic pain, attention problems, or medical illness. Bipolar disorder can include depressive episodes, but its treatment plan may differ from care for major depressive disorder. Periods of unusually high energy, reduced need for sleep, racing thoughts, or impulsive behavior should always be reported.
In addition, the National Institute of Mental Health notes that thyroid disorders, viruses, and some medications can cause symptoms that resemble depression.[5] A psychiatric reassessment may include a physical examination, laboratory testing, or coordination with primary care when the history points in that direction.
7. Symptoms keep worsening despite consistent care
Increasing hopelessness, inability to complete basic tasks, greater isolation, frequent absences, or growing thoughts about death require prompt clinical attention. Worsening symptoms should not wait for a routine appointment if safety is becoming uncertain.
What does not automatically mean your depression is treatment resistant?
Still, one medication that did not help is usually too little information. A short trial, a dose that never reached a therapeutic level, frequent missed doses, or stopping because of side effects may also require a different interpretation.
Other possibilities include:
- the treatment did not have enough time to work;
- follow-up visits were too far apart to adjust the plan;
- psychotherapy was not matched to the person’s needs;
- sleep apnea, thyroid disease, pain, or another medical issue was untreated;
- alcohol or other substances were worsening mood and sleep;
- the diagnosis needs revision; or
- the medication helped some symptoms while important functional problems remained.
This is why counting medication bottles at home cannot replace an evaluation. The goal is to understand the full course of illness and make a more precise next decision.
What should a psychiatric reassessment include?
A useful reassessment starts with the story of the current episode and then checks the records. Expect discussion of:
- when symptoms began and how they changed;
- current safety and any suicidal thoughts;
- every previous antidepressant, dose, duration, benefit, and side effect;
- psychotherapy type, frequency, and outcome;
- sleep, appetite, energy, concentration, and physical symptoms;
- periods of high energy, reduced sleep, or unusual impulsivity;
- alcohol, cannabis, and other substance use;
- medical conditions, medications, supplements, and recent laboratory work;
- family psychiatric history; and
- work, school, relationships, caregiving, and daily routines.
Measurement-based care can make gradual change easier to see. For example, tools such as the Patient Health Questionnaire-9 can support the conversation when the same measure is repeated over time. A score should inform clinical judgment rather than replace it.
Treatment-resistant depression next steps
The next treatment depends on the diagnosis, urgency, previous response, side effects, medical history, preferences, and insurance rules. A psychiatrist may discuss:
- optimizing the current antidepressant dose or duration;
- switching to another antidepressant;
- adding a second medication to support the antidepressant response;
- using a structured psychotherapy or changing the therapy approach;
- treating sleep, pain, substance use, or another condition that is slowing recovery;
- transcranial magnetic stimulation;
- electroconvulsive therapy for severe or urgent situations; or
- a coordinated plan that combines several of these approaches.
The National Institute of Mental Health describes brain-stimulation therapies as established options for certain people whose depression has not improved with medication or psychotherapy.[6] Each option has different evidence, preparation, risks, time commitments, and insurance criteria.
How TMS may fit into a treatment plan
Transcranial magnetic stimulation uses rapidly pulsed magnetic fields to stimulate targeted areas of the cerebral cortex. The U.S. Food and Drug Administration classifies repetitive TMS systems for major depressive disorder as Class II medical devices with special controls.[7]
TMS is provided in an outpatient setting while the patient is awake. It does not require anesthesia. Candidacy still requires a clinical and safety evaluation, including a review of seizure risk, neurological history, medications, and metal or implanted devices in or near the head.
At Kalamazoo TMS & Behavioral Health, a typical NeuroStar course may involve 36 sessions over approximately 6 weeks, often 5 visits per week. The exact protocol and schedule depend on the clinician’s recommendation and the device’s cleared indication.
Read TMS Therapy in Kalamazoo: 7 Questions to Ask for a consultation checklist. The clinic’s TMS therapy page explains the treatment process, and the insurance guide covers documents that may be needed for prior authorization.
What to bring to your appointment
You do not need a perfectly organized history. Start with what is available:
- a current medication and supplement list;
- pharmacy records for previous antidepressants;
- names of previous prescribers and therapists;
- approximate medication doses and dates;
- notes about benefit, side effects, and reasons for stopping;
- recent laboratory results, if available;
- your insurance card; and
- two examples of how symptoms affect daily life.
Choose concrete examples. “I have missed four workdays this month” or “I stopped cooking dinner three weeks ago” gives the clinician more information than a general statement that things feel bad.
When to seek urgent help
Call or text 988 for the Suicide & Crisis Lifeline if you are having thoughts of suicide or need immediate emotional support. Call 911 or go to the nearest emergency department when there is immediate danger, a suicide attempt, or an inability to stay safe.
Frequently asked questions
Can treatment-resistant depression still improve?
Yes. The term describes the response to previous treatments, not a prediction about every future option. A reassessment can identify an incomplete medication trial, an overlooked diagnosis, a medical contributor, a psychotherapy change, or an advanced treatment that has not yet been considered.
How many medications must fail before depression is treatment resistant?
A common definition is inadequate improvement after at least two antidepressants taken at a suitable dose and duration. Research studies and insurance plans may use different criteria, so a psychiatrist should review the exact treatment history rather than relying on the medication count alone.
Is TMS used for treatment-resistant depression?
TMS is one option for some people with major depressive disorder who did not benefit enough from antidepressant medication. A psychiatrist must confirm the diagnosis, review previous treatments, screen for safety concerns, and determine whether the proposed TMS device and protocol fit the person’s clinical needs.
Should I stop my antidepressant if it is not helping?
Do not stop or change an antidepressant without guidance from the prescribing clinician. Sudden changes can cause withdrawal symptoms or worsening mood. Contact the prescriber to review the dose, duration, side effects, adherence, and a safe plan for any adjustment.
When is depression an emergency?
Seek urgent help when there are suicidal thoughts with intent or a plan, a recent attempt, an inability to stay safe, severe confusion, psychosis, or dangerous behavior. Call 911 or go to the nearest emergency department for immediate danger. Call or text 988 for crisis support.
A more complete review can create a better next step
Living with treatment-resistant depression can make each new appointment feel harder to begin. Bring the records you have, describe what daily life looks like now, and ask the clinician to review the diagnosis and every previous treatment with you.
Kalamazoo TMS & Behavioral Health provides psychiatric evaluations and TMS consultations at its Portage office for people from Kalamazoo, Battle Creek, Paw Paw, Comstock, Oshtemo, Texas Corners, Mattawan, Vicksburg, Grand Rapids, and nearby Michigan communities. Request a new-patient appointment or call 269-381-6950.
This article is educational and does not replace medical advice, diagnosis, or emergency care. Do not start, stop, or change medication without speaking with the prescribing clinician.
References
- National Institute of Mental Health. Depression. View source
- Agency for Healthcare Research and Quality. Definition of Treatment-Resistant Depression in the Medicare Population. View source
- National Institute of Mental Health. STAR-D Study, Level 1 Results. View source
- Nierenberg AA, et al. Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR-D report. Psychological Medicine. 2010;40(1):41-50. View source
- National Institute of Mental Health. Depression: How is depression diagnosed? View source
- National Institute of Mental Health. Brain Stimulation Therapies. View source
- U.S. Food and Drug Administration. Repetitive Transcranial Magnetic Stimulation Systems: Class II Special Controls Guidance. View source
